Nemaura Medical (NMRD) Competitors $0.0002 0.00 (0.00%) As of 04/17/2025 09:30 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsSustainabilityTrendsBuy This Stock NMRD vs. VRAYQ, AHPI, VIVE, UTRS, MOTS, DRTSW, ANZUW, IONM, ATAKW, and BBLGWShould you be buying Nemaura Medical stock or one of its competitors? The main competitors of Nemaura Medical include ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Viveve Medical (VIVE), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Assure (IONM), Aurora Technology Acquisition (ATAKW), and Bone Biologics (BBLGW). These companies are all part of the "medical equipment" industry. Nemaura Medical vs. ViewRay Allied Healthcare Products Viveve Medical Minerva Surgical Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I Assure Aurora Technology Acquisition Bone Biologics ViewRay (NASDAQ:VRAYQ) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, community ranking, dividends, media sentiment and analyst recommendations. Does the MarketBeat Community favor VRAYQ or NMRD? Nemaura Medical received 4 more outperform votes than ViewRay when rated by MarketBeat users. CompanyUnderperformOutperformViewRayN/AN/ANemaura MedicalOutperform Votes457.14% Underperform Votes342.86% Is VRAYQ or NMRD more profitable? Company Net Margins Return on Equity Return on Assets ViewRayN/A N/A N/A Nemaura Medical N/A N/A N/A Do insiders & institutionals hold more shares of VRAYQ or NMRD? 15.5% of ViewRay shares are owned by institutional investors. Comparatively, 4.4% of Nemaura Medical shares are owned by institutional investors. 2.5% of ViewRay shares are owned by insiders. Comparatively, 40.4% of Nemaura Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media refer more to VRAYQ or NMRD? In the previous week, ViewRay's average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score. Company Overall Sentiment ViewRay Neutral Nemaura Medical Neutral Which has better valuation and earnings, VRAYQ or NMRD? Nemaura Medical has lower revenue, but higher earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViewRay$102.21M0.00-$107.33MN/AN/ANemaura Medical$3.02K2.67-$14.14M-$0.390.00 Which has more volatility and risk, VRAYQ or NMRD? ViewRay has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. SummaryViewRay and Nemaura Medical tied by winning 3 of the 6 factors compared between the two stocks. Get Nemaura Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter. Email Address NMRD vs. The Competition Export to ExcelMetricNemaura MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$8,000.00$4.07B$5.31B$7.35BDividend YieldN/A46.44%5.47%4.31%P/E Ratio0.0028.0921.9417.82Price / Sales2.6747.06380.9497.72Price / CashN/A51.0838.3134.64Price / Book0.005.816.453.98Net Income-$14.14M$67.09M$3.22B$247.81M7 Day PerformanceN/A1.83%5.85%3.19%1 Month PerformanceN/A-11.62%-9.58%-7.70%1 Year PerformanceN/A15.43%11.85%1.49% Nemaura Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMRDNemaura MedicalN/A$0.00flatN/A-99.8%$8,000.00$3,017.000.0040VRAYQViewRayN/A$0.00+∞N/AN/A$18,000.00$102.21M0.00300Gap UpAHPIAllied Healthcare ProductsN/AN/AN/AN/A$16,000.00$27.05M0.00150Analyst ForecastNews CoverageGap UpVIVEViveve MedicalN/A$0.00flatN/A+0.0%$2,000.00$6.83M0.0070UTRSMinerva SurgicalN/AN/AN/AN/A$1,000.00$51.69M0.00160MOTSMotus GIN/A$0.00flatN/A-99.9%$1,000.00$319,000.000.0030DRTSWAlpha Tau MedicalN/A$0.21+2.7%N/AN/A$0.00N/A0.0080Gap DownANZUWAnzu Special Acquisition Corp IN/A$0.03flatN/AN/A$0.00N/A0.002IONMAssureN/AN/AN/AN/A$0.00$149,000.000.00130Upcoming EarningsATAKWAurora Technology AcquisitionN/A$0.01-5.0%N/A-62.3%$0.00N/A0.00N/ABBLGWBone BiologicsN/A$20.20-2.9%N/AN/A$0.00N/A0.002Gap Up Related Companies and Tools Related Companies VRAYQ Competitors AHPI Competitors VIVE Competitors UTRS Competitors MOTS Competitors DRTSW Competitors ANZUW Competitors IONM Competitors ATAKW Competitors BBLGW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMRD) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nemaura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
